Europe Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Country: COVID-19 Impact and Growth Opportunity

Get in-depth COVID-19 impact and recovery analysis on the Europe Preventive Vaccines Market

Flash Discount
15% Single User
20% Multi User
25% Corporate
30% Enterprise
  • Europe preventive vaccines market accounted for $10.64 billion in 2020 and will grow by 10.72% annually over 2020-2026 owing to the increasing healthcare expenditure, new development of the vaccines, and rising need for preventive vaccines especially new COVID-19 vaccines.

    Highlighted with 61 tables and 52 figures, this 140-page report “Europe Preventive Vaccines Market 2020-2026 by Vaccine Type, Disease, Administration, Patient, and Country: COVID-19 Impact and Growth Opportunity” is based on a holistic research of the entire Europe preventive vaccines market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2016-2019 and provides estimate/forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

    In-depth qualitative analyses include identification and investigation of the following aspects:

    • Market Structure

    • Growth Drivers

    • Restraints and Challenges

    • Emerging Product Trends & Market Opportunities

    • Porter’s Fiver Forces

    The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe preventive vaccines market in every aspect of the classification from perspectives of Vaccine Type, Disease, Administration, Patient, and Country.

    Based on Vaccine Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Live/Attenuated Vaccines

    • Inactivated Vaccines

    • Subunit Vaccines

    • Toxoid Vaccines

    • Conjugate Vaccines

    • Recombinant Vector Vaccines

    • Other Vaccines

    Based on Disease, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Vaccines for Pneumococcal Disease

    • Vaccines for Poliovirus

    • Vaccines for Hepatitis

    • Vaccines for Influenza

    • Vaccines for Measles, Mumps, and Rubella (MMR)

    • Vaccines for Varicella

    • Vaccines for Human Papilloma Virus

    • Vaccines for COVID-19

    • Vaccines for Other Diseases

    Based on Administration, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Intramuscular Route

    • Subcutaneous Route

    • Oral Route

    • Intravenous Injection

    • Other Administration Routes

    Based on Patient, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2016-2026 included in each section.

    • Pediatric Vaccines

    o Pneumococcal

    o Measles, Mumps, and Rubella (MMR)

    o Varicella

    o Hepatitis

    o Poliovirus

    o Haemophilus Influenzae B (HIB)

    o Other Diseases

    • Adult Vaccines

    o Influenza

    o Cervical Cancer

    o Hepatitis

    o Zoster

    o Other Diseases

    Geographically, the following national/local markets are fully investigated:

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Russia

    • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

    For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2016-2026. The breakdown of key national markets by Vaccine Type, Disease, and Route of Administration over the forecast years are also included.

    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

    Specifically, potential risks associated with investing in Europe preventive vaccines market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

    Key Players (this may not be a complete list and extra companies can be added upon request):

    AstraZeneca plc

    Bavarian Nordic A/S

    China National Biotec Group Company Ltd.

    CSL Ltd.

    Daiichi Sankyo Co. Ltd

    Emergent BioSolutions Inc.

    GlaxoSmithKline plc

    Johnson & Johnson

    Merck & Co.

    Moderna Inc.

    Novavax, Inc.

    Pfizer Inc.

    Sanofi SA

    Takeda Pharmaceutical Co. Ltd.

    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

     

  • With tables and figures helping analyze worldwide Europe Preventive Vaccines market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


    1 Introduction 7

    1.1 Industry Definition and Research Scope 7

    1.1.1 Industry Definition 7
    1.1.2 Research Scope 8

    1.2 Research Methodology 11

    1.2.1 Overview of Market Research Methodology 11
    1.2.2 Market Assumption 12
    1.2.3 Secondary Data 12
    1.2.4 Primary Data 12
    1.2.5 Data Filtration and Model Design 13
    1.2.6 Market Size/Share Estimation 14
    1.2.7 Research Limitations 15

    1.3 Executive Summary 16


    2 Market Overview and Dynamics 19

    2.1 Market Size and Forecast 19

    2.1.1 Impact of COVID-19 on World Economy 21
    2.1.2 Impact of COVID-19 on the Market 23

    2.2 Major Growth Drivers 25

    2.3 Market Restraints and Challenges 28

    2.4 Emerging Opportunities and Market Trends 31

    2.5 Porter’s Fiver Forces Analysis 35


    3 Segmentation of Europe Market by Vaccine Type 39

    3.1 Market Overview by Vaccine Type 39

    3.2 Live/Attenuated Vaccines 41

    3.3 Inactivated Vaccines 42

    3.4 Subunit Vaccines 43

    3.5 Toxoid Vaccines 44

    3.6 Conjugate Vaccines 45

    3.7 Recombinant Vector Vaccines 46
    3.8 Other Vaccines 47

    4 Segmentation of Europe Market by Disease 48

    4.1 Market Overview by Disease 48

    4.2 Vaccines for Pneumococcal Disease 50

    4.3 Vaccines for Poliovirus 51

    4.4 Vaccines for Hepatitis 52

    4.5 Vaccines for Influenza 53

    4.6 Vaccines for Measles, Mumps, and Rubella (MMR) 54

    4.7 Vaccines for Varicella 55
    4.8 Vaccines for Human Papilloma Virus 56
    4.9 Vaccines for COVID-19 57
    4.10 Vaccines for Other Diseases 60

    5 Segmentation of Europe Market by Administration 61

    5.1 Market Overview by Administration 61

    5.2 Intramuscular Route 63

    5.3 Subcutaneous Route 64

    5.4 Oral Route 65

    5.5 Intravenous Injection 66

    5.6 Other Administration Routes 67


    6 Segmentation of Europe Market by Patient 68

    6.1 Market Overview by Patient 68

    6.2 Pediatric Vaccines 70

    6.3 Adult Vaccines 72


    7 European Market 2020-2026 by Country 74

    7.1 Overview of European Market 74

    7.2 UK 77

    7.3 France 80

    7.4 Germany 83

    7.5 Spain 86

    7.6 Italy 89

    7.7 Russia 92
    7.8 Rest of European Market 95

    8 Competitive Landscape 97

    8.1 Overview of Key Vendors 97

    8.2 New Product Launch, Partnership, Investment, and M&A 100

    8.3 Company Profiles 101

    AstraZeneca plc 101
    Bavarian Nordic A/S 104
    China National Biotec Group Company Ltd. 107
    CSL Ltd. 109
    Daiichi Sankyo Co. Ltd 111
    Emergent BioSolutions Inc. 113
    GlaxoSmithKline plc 115
    Johnson & Johnson 119
    Merck & Co. 121
    Moderna Inc. 123
    Novavax, Inc. 124
    Pfizer Inc. 126
    Sanofi SA 130
    Takeda Pharmaceutical Co. Ltd. 132

    9 Investing in Europe Market: Risk Assessment and Management 134

    9.1 Risk Evaluation of Europe Market 134

    9.2 Critical Success Factors (CSFs) 137

    Related Reports and Products 140

     

  • The Europe Preventive Vaccines Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • AstraZeneca plc Bavarian Nordic A/S China National Biotec Group Company Ltd. CSL Ltd. Daiichi Sankyo Co. Ltd Emergent BioSolutions Inc. GlaxoSmithKline plc Johnson & Johnson Merck & Co. Moderna Inc. Novavax
    • Inc. Pfizer Inc. Sanofi SA Takeda Pharmaceutical Co. Ltd.
    By Regions:
      By Type:
        By Application:
        Licensing options
        2700
        USD

        Need assistance ?

        Research objectives

        Where will all these developments take the industry in the long

        To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

        What are the future opportunities in the market?

        To understand the structure of Market by identifying its various subsegments.

        What are the major driving forces expected to impact the development of the market market across different regions?

        To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

        Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

        To project the consumption of market submarkets, with respect to key regions.

        Who are the major driving forces expected to decide the fate of the industry worldwide.

        To strategically profile the key players and comprehensively analyze their growth strategies.

        What are the key barriers and threats believed to hinder the development of the industry?

        To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

        Who are the prominent market players making a mark in the market with their winning strategies?

        To share detailed information about the key factors influencing the growth of the market

        What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

        Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

        Our Clients